Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES : FAMU Professor Receives Patent for Highly Effective Anti-HIV Compounds (Valdosta) (12.12.12) Aids Weekly Plus

Kinfe Ken Redda, interim vice president of research at Florida A&M University (FAMU), and his research team have received a patent for the development of therapeutic agents suitable for treating humans who are infected with HIV. They were awarded US Patent #8,314,143 titled, “Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of HIV Infection and other Pathologies.” Redda was principal investigator and co-inventor. The patent includes a group of compounds called flavonoids. Flavonoids are present in vascular plants and are known for their range of biological activities. Redda’s team has developed compounds that are synthetic flavonoid derivatives designed to target a specific enzyme, HIV integrase. Redda stated that the compounds showed superior inhibitory activities compared to zidovudine (AZT), a drug used for HIV treatment. He admits that there is a long way to go before the right remedy for treating HIV is developed, but Redda believes that they have taken the first step, and sees great potential for the compounds to become an effective HIV/AIDS treatment.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in December 13, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.